Axerion Therapeutics
Connecticut-based Axerion Therapeutics innovates neurological disease and injury treatments.
Founded
2009Connecticut-based Axerion Therapeutics innovates neurological disease and injury treatments.
Axerion Therapeutics, founded in Branford, Connecticut, is a biotech company dedicated to developing innovative treatments for neurological diseases and injuries. The company's core mission is to advance therapeutic options that address unmet medical needs in neurology, with a vision to improve the quality of life for patients suffering from these conditions. Axerion Therapeutics focuses on creating novel therapeutics that target specific neurological pathways, aiming to provide effective solutions for conditions such as spinal cord injuries and neurodegenerative diseases.
Notable figures associated with Axerion Therapeutics include leading scientists and researchers in the field of neurology. The company has garnered attention from prominent investors in the biotech sector, supporting its research and development efforts. Axerion Therapeutics has achieved significant milestones in preclinical studies, demonstrating the potential efficacy of its therapeutic candidates. The overall impact of Axerion Therapeutics lies in its commitment to pioneering advancements in neurological treatments, offering hope and potential recovery for patients with debilitating neurological conditions.
Companies similar to Axerion Therapeutics include Axonis Therapeutics, Axonia Medical, Axsome Therapeutics and Axial Therapeutics.
Axerion Therapeutics was founded in 2009.
Axerion Therapeutics' headquarters is located in Branford, CT, US.
Axerion Therapeutics' most recent funding round was for $400k (USD) in October 2011.
As of Oct 13, 2011, Axerion Therapeutics has raised a total of $1.1M (USD).
Axerion Therapeutics has 34 employees as of Feb 4, 2024.
axsome.com
